Part of Phaidon International![]()
Showing 83 results
Sort by:
Head of EHSLocation: Günzburg, Bavaria, GermanySalary: €90,000 to €110,000 + Bonus Are you an HSE leader from the chemical industry ready to take ownership of safety, quality and environmental standards at a major manufacturing site?Do you have the technical credibility and leadership style to drive compliance, influence people on the plant floor a...
Our client is an innovative Class III medical device company developing and manufacturing life-sustaining technologies that improve patient outcomes worldwide. We are seeking a Director of Quality to lead quality strategy, quality systems, and manufacturing quality across product development and commercial operations.Position SummaryThe Director of...
Quality Assurance Specialist - Entry LevelLocation: West of Berlin, GermanyWorking Pattern: Full-Time, On-SiteIndustry: Pharmaceutical Manufacturing________________________________________About the OpportunityEPM Scientific is supporting a global leader in the development and manufacture of dietary supplements, pharmaceutical products, and function...
Quality Assurance Specialist - Entry LevelLocation: West of Berlin, GermanyWorking Pattern: Full-Time, On-SiteIndustry: Pharmaceutical Manufacturing________________________________________About the OpportunityEPM Scientific is supporting a global leader in the development and manufacture of dietary supplements, pharmaceutical products, and function...
The OpportunityA growing bio-pharmaceutical company is seeking a Senior Manager, Clinical Quality to provide quality oversight across clinical studies and vendor programs.This role will partner closely with clinical teams, CROs, and vendors to ensure GCP compliance, support inspection readiness, and drive quality throughout the clinical development...
Role: VP of Quality Location: Boston, MA (On-site)Salary: $250k-$350kEPM Scientific is partnering with a rapidly growing structural heart medical device company that is advancing innovative therapies for patients with complex cardiovascular conditions. Following significant clinical progress, strong investor backing, and continued organizational gr...